Executive Vice President for International Affairs at the Biotechnology Innovation Organization (BIO)
Mr. Damond is responsible for developing and implementing the industry association’s international advocacy and outreach program, including the areas of trade policy and foreign government relations. Prior to taking up this position at BIO, Mr. Damond was vice president for International Government Relations in Pfizer’s Washington office from 2006-2011.
Edward Kliphuis joined the previous biopharma fund MS Ventures in 2014 and transitioned to Investment Director New Businesses. Previously, Edward was at Kempen & Co, a pan-European merchant bank based in Amsterdam, where he was on the Life Sciences Securities team. He was instrumental in the team’s ongoing fundraising efforts for listed European small- and mid-cap biotech companies in over 20 deals in 2012 and 2013. Edward holds an MSc in Biopharmaceutical Sciences from Leiden University, the Netherlands, specializing in pharmacology and science-based business.
Director of the Barcelona Institute of Science and Technology (BIST) and the Institute of Chemical Research of Catalonia (ICIQ)
Since October 2016, Dr. Pericàs has combined his position as director of the ICIQ with the responsibility of heading up BIST. Before taking on the role as director of the ICIQ in 2000, he was a professor of Organic Chemistry at the University of Barcelona. Pericàs’s research career focused on chemistry and has received Catalan government's Distinction for the Promotion of University Research, the Janssen-Cylag Award from the Spanish Royal Society of Chemistry and the Narcís Monturiol Medal from the Government of Catalonia.